Cookie Settings

We use cookies to optimize our website. These include cookies that are necessary for the operation of the site, as well as those that are only used for anonymous statistic. You can decide for yourself which categories you want to allow. Further information can be found in our data privacy protection .


These cookies are necessary to run the core functionalities of this website and cannot be disabled.

Name Webedition CMS
Purpose This cookie is required by the CMS (Content Management System) Webedition for the system to function correctly. Typically, this cookie is deleted when the browser is closed.
Name econda
Purpose Session cookie emos_jcsid for the web analysis software econda. This runs in the “anonymized measurement” mode. There is no personal reference. As soon as the user leaves the site, tracking is ended and all data in the browser are automatically deleted.

These cookies help us understand how visitors interact with our website by collecting and analyzing information anonymously. Depending on the tool, one or more cookies are set by the provider.

Name econda
Purpose Statistics
External media

Content from external media platforms is blocked by default. If cookies from external media are accepted, access to this content no longer requires manual consent.

Name YouTube
Purpose Show YouTube content
Name Twitter
Purpose activate Twitter Feeds

European excellence grant for DKFZ researcher

No. 09 | 14/02/2018 | by Koh

The ERC Consolidator Grants by the European Research Council (ERC) support excellent researchers to help them consolidate their independent career. Ana Martin-Villalba from the German Cancer Research Center (DKFZ) has now received this prestigious ERC grant. Martin-Villalba will use the €2 million grant to investigate how repair processes can be stimulated in the adult brain following injury or disease. Martin-Villalba plans to specifically activate the development potential of stem cells in the brain to replace lost brain cells.

Ana Martin-Villalba
© Tobias Schwerdt/DKFZ

Our brain is composed of numerous different types of nerve cells (neurons) and a wide variety of glial cells that have important supportive and regulatory tasks. While brain stem cells in the embryo give rise to this diversity of cell types, this can no longer be accomplished in the adult brain. Although progenitor cells are present, they can no longer differentiate into the various cell types.

Martin-Villalba now intends to find out why this is so. During her whole scientific career, the scientist has studied possibilities to stimulate repair processes in the central nervous system (CNS). Just recently, she discovered that injuries of the CNS lead to characteristic changes in the gene activity of brain stem cells. This causes the stem cells to awaken from their dormant state, in which they normally protect themselves from harmful environmental influences. In addition, injuries activate specific gene enhancers that are important players in developmental biology and that are normally silenced by the presence of epigenetic labels.

In her ERC funded work, Martin Villalba plans to investigate how these gene enhancers can be used to stimulate the complete development program in stem cells that gives rise to the variety of mature brain cells. A particular challenge in this is to proceed very specifically so as not to cause cancer by excessive activation.

Using most advanced methods, Martin-Villalba plans to trace the development paths of individual stem cells. The goal is to influence the brain stem cells in such a way that they renew brain areas which have been destroyed as a result of injury or disease.

Ana Martin-Villalba studied Medicine at the University of Murcia, Spain, and in Leeds, United Kingdom. She graduated in 1995 and earned a PhD degree in 1998 at Heidelberg University, where she had studied the role of death ligands (CD95L, TNF and TRAIL) in apoptosis in the human brain after a stroke. Following clinical work at Heidelberg University Hospital and a post as a project leader in Peter Krammer's department at the German Cancer Research Center (DKFZ), Martin-Villalba built up the DKFZ Junior Research Group "Molecular Neurobiology", which was converted into a department in 2011.

Martin-Villalba has previously been honored for her research results with the Paul Ehrlich and Ludwig Darmstaedter Prize for Young Researchers, the Heinz Maier-Leibnitz Prize of the German Research Foundation (DFG) and the Walther and Christine Richtzenhain Prize.

A picture of Ana Martin-Villalba is available for download:

Note on use of images related to press releases
Use is free of charge. The German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) permits one-time use in the context of reporting about the topic covered in the press release. Images have to be cited as follows: "Source: Tobias Schwerdt/DKFZ".
Distribution of images to third parties is not permitted unless prior consent has been obtained from DKFZ's Press Office (phone: ++49-(0)6221 42 2854, E-mail: Any commercial use is prohibited.

With more than 3,000 employees, the German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) is Germany’s largest biomedical research institute. DKFZ scientists identify cancer risk factors, investigate how cancer progresses and develop new cancer prevention strategies. They are also developing new methods to diagnose tumors more precisely and treat cancer patients more successfully. The DKFZ's Cancer Information Service (KID) provides patients, interested citizens and experts with individual answers to questions relating to cancer.

To transfer promising approaches from cancer research to the clinic and thus improve the prognosis of cancer patients, the DKFZ cooperates with excellent research institutions and university hospitals throughout Germany:

  • National Center for Tumor Diseases (NCT, 6 sites)
  • German Cancer Consortium (DKTK, 8 sites)
  • Hopp Children's Cancer Center (KiTZ) Heidelberg
  • Helmholtz Institute for Translational Oncology (HI-TRON Mainz) - A Helmholtz Institute of the DKFZ
  • DKFZ-Hector Cancer Institute at the University Medical Center Mannheim
  • National Cancer Prevention Center (jointly with German Cancer Aid)
The DKFZ is 90 percent financed by the Federal Ministry of Education and Research and 10 percent by the state of Baden-Württemberg. The DKFZ is a member of the Helmholtz Association of German Research Centers.


Subscribe to our RSS-Feed.

to top
powered by webEdition CMS